Filter By:

Drug delivery technique makes cancer immunotherapy more effective

Researchers in the Institute for Molecular Engineering at the University of Chicago (IME) have developed a new way to target immunotherapies and deliver them directly to tumors.

Three years after CAR T-cell therapy for lymphoma, patient still cancer-free
Novel biomarker found in ovarian cancer patients can predict response to therapy